• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

toll 样受体信号通路及 toll 样受体信号与心肌缺血/再灌注损伤关联的证据。

Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury.

机构信息

Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.

出版信息

Shock. 2010 Dec;34(6):548-57. doi: 10.1097/SHK.0b013e3181e686f5.

DOI:10.1097/SHK.0b013e3181e686f5
PMID:20458266
Abstract

Toll-like receptors (TLRs) play a key role in innate immune defenses. After activation by foreign pathogens or host-derived molecules, TLRs signal via overlapping or distinct signaling cascades and eventually induce numerous genes involved in a variety of cellular responses. A growing body of evidence suggests that TLR signaling also plays an important role in cardiac ischemia/reperfusion injury. We review our current understanding of the TLR signaling pathways and their roles in the pathophysiology of cardiac ischemia/reperfusion injury, as well as discuss several mechanisms for TLR activation and regulation.

摘要

Toll 样受体(TLRs)在先天免疫防御中发挥关键作用。在被外来病原体或宿主来源的分子激活后,TLRs 通过重叠或不同的信号级联传递信号,最终诱导多种参与各种细胞反应的基因。越来越多的证据表明,TLR 信号在心肌缺血/再灌注损伤中也起着重要作用。我们综述了目前对 TLR 信号通路及其在心肌缺血/再灌注损伤病理生理学中的作用的理解,并讨论了 TLR 激活和调节的几种机制。

相似文献

1
Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury. toll 样受体信号通路及 toll 样受体信号与心肌缺血/再灌注损伤关联的证据。
Shock. 2010 Dec;34(6):548-57. doi: 10.1097/SHK.0b013e3181e686f5.
2
Toll-like receptors: a novel target for therapeutic intervention in intestinal and hepatic ischemia-reperfusion injury? Toll 样受体:治疗肠和肝缺血再灌注损伤的新靶点?
Expert Opin Ther Targets. 2010 Aug;14(8):839-53. doi: 10.1517/14728222.2010.500286.
3
Toll-like receptors in ischemia-reperfusion injury.缺血再灌注损伤中的Toll样受体
Shock. 2009 Jul;32(1):4-16. doi: 10.1097/SHK.0b013e318193e333.
4
[Frontier of mycobacterium research--host vs. mycobacterium].[分枝杆菌研究前沿——宿主与分枝杆菌]
Kekkaku. 2005 Sep;80(9):613-29.
5
The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.Toll 样受体信号通路在无菌性炎症性疾病中的重要作用。
Int Immunopharmacol. 2011 Oct;11(10):1422-32. doi: 10.1016/j.intimp.2011.04.026. Epub 2011 May 18.
6
Toll-like receptor and RIG-I-like receptor signaling.Toll样受体和视黄酸诱导基因I样受体信号通路。
Ann N Y Acad Sci. 2008 Nov;1143:1-20. doi: 10.1196/annals.1443.020.
7
TLRs and chronic inflammation.TLRs 与慢性炎症。
Int J Biochem Cell Biol. 2010 Apr;42(4):495-505. doi: 10.1016/j.biocel.2009.10.010. Epub 2009 Oct 17.
8
Chemokines in ischemia and reperfusion.缺血再灌注中的趋化因子。
Thromb Haemost. 2007 May;97(5):738-47.
9
Mechanisms of disease: Toll-like receptors in cardiovascular disease.疾病机制:心血管疾病中的Toll样受体
Nat Clin Pract Cardiovasc Med. 2007 Aug;4(8):444-54. doi: 10.1038/ncpcardio0938.
10
TRAF3: a new component of the TLR-signaling apparatus.肿瘤坏死因子受体相关因子3:Toll样受体信号传导装置的一个新组分
Trends Mol Med. 2006 May;12(5):187-9. doi: 10.1016/j.molmed.2006.03.008. Epub 2006 Apr 18.

引用本文的文献

1
Endothelial Dysfunction and Cardiovascular Disease: Hyperbaric Oxygen Therapy as an Emerging Therapeutic Modality?内皮功能障碍与心血管疾病:高压氧治疗会成为一种新兴的治疗方式吗?
J Cardiovasc Dev Dis. 2024 Dec 19;11(12):408. doi: 10.3390/jcdd11120408.
2
Endothelial Dysfunction in Patients Undergoing Cardiac Surgery: A Narrative Review and Clinical Implications.心脏手术患者的内皮功能障碍:一项叙述性综述及临床意义
J Cardiovasc Dev Dis. 2023 May 13;10(5):213. doi: 10.3390/jcdd10050213.
3
TJ-M2010-5 Attenuates Severe Myocardial Ischemia/Reperfusion Injury in Heart Transplantation by Inhibiting MyD88 Homodimerization In Vivo.
TJ-M2010-5 通过抑制体内 MyD88 同源二聚体减轻心脏移植中的严重心肌缺血/再灌注损伤。
J Cardiovasc Transl Res. 2022 Dec;15(6):1366-1376. doi: 10.1007/s12265-022-10246-9. Epub 2022 Apr 11.
4
Rapid Lipid Modification of Endothelial Cell Membranes in Cardiac Ischemia/Reperfusion Injury: a Novel Therapeutic Strategy to Reduce Infarct Size.心肌缺血/再灌注损伤中内皮细胞膜的快速脂质修饰:一种减小梗死面积的新治疗策略。
Cardiovasc Drugs Ther. 2021 Feb;35(1):113-123. doi: 10.1007/s10557-020-07101-x. Epub 2020 Oct 20.
5
Gene expression profiling analysis to investigate the role of remote ischemic postconditioning in ischemia-reperfusion injury in rats.基因表达谱分析探讨远程缺血后处理在大鼠缺血再灌注损伤中的作用。
BMC Genomics. 2019 May 9;20(1):361. doi: 10.1186/s12864-019-5743-9.
6
Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury.补体因子B的激活会导致小鼠和人类心肌缺血/再灌注损伤。
PLoS One. 2017 Jun 29;12(6):e0179450. doi: 10.1371/journal.pone.0179450. eCollection 2017.
7
The role of Toll-like receptors in retinal ischemic diseases.Toll样受体在视网膜缺血性疾病中的作用。
Int J Ophthalmol. 2016 Sep 18;9(9):1343-51. doi: 10.18240/ijo.2016.09.19. eCollection 2016.
8
Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor.缺血/再灌注激活心肌固有免疫反应:Toll样受体的关键作用。
Front Physiol. 2014 Dec 18;5:496. doi: 10.3389/fphys.2014.00496. eCollection 2014.
9
Intrathecal antagonism of microglial TLR4 reduces inflammatory damage to blood-spinal cord barrier following ischemia/reperfusion injury in rats.大鼠缺血/再灌注损伤后,小胶质细胞Toll样受体4的鞘内拮抗作用可减轻对血脊髓屏障的炎性损伤。
Mol Brain. 2014 Apr 21;7:28. doi: 10.1186/1756-6606-7-28.
10
Effects and mechanisms of chinese herbal medicine in ameliorating myocardial ischemia-reperfusion injury.中药改善心肌缺血再灌注损伤的作用及机制。
Evid Based Complement Alternat Med. 2013;2013:925625. doi: 10.1155/2013/925625. Epub 2013 Oct 31.